Letter: Efficacy and Safety of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Journal
- Dermatitis : contact, atopic, occupational, drug (Q1)
- Published
- 15 July 2026
- Study design
- Narrative review / expert opinion
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Sana Gupta, Jia Qi Adam Bai, Ilya Mukovozov
- PMID
- 42458966
- DOI
- 10.1177/17103568261470925
Why clinicians should know about it
- Picked for Dermatology (top studies of the week, 19 July 2026): Recent Dermatology research from a high-quartile journal
- Picked for Immunology and Allergy (top studies of the week, 19 July 2026).
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.